Data / Drug companies / Sodium bicarbonate
Sodium bicarbonate: 51 companies and 89 products in the FDA NDC directory
Sodium bicarbonate is listed in the FDA National Drug Code Directory by 51 companies, with 89 products in commercial distribution. 37 of the products (41.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; tablet; powder, and the newest product started marketing on August 14, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 51
- Products
- 89
- Generic (ANDA) products
- 37 (41.6%)
- Application numbers
- 19
- Routes
- Intravenous, Oral, Topical
- Brand names
- Ahhh Bite Relief, After Bite X Tech, DR. Sana Bicarbonato de Sodio 4 Fl Oz and 6 Floz, Anti-Empacho, D-D Sudium Bicarbonate U.s.p. Bicarbonato de Soda Puro, After Bite Kids, Insect Sting Relief Pad 01, Insect Sting Relief Latex 01
- openFDA record search
- api.fda.gov
Companies that list sodium bicarbonate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Exela Pharma Sciences, LLC | 6 | injection, solution | Generic drugs (ANDA) | September 1, 2020 |
| Medical Purchasing Solutions, LLC | 6 | injection, solution; injection | Generic drugs (ANDA) | August 7, 2025 |
| HF Acquisition Co LLC, DBA HealthFirst | 5 | injection, solution; injection | Other unapproved drugs | February 18, 2022 |
| Hospira, Inc. | 5 | injection, solution | Generic drugs (ANDA) | March 1, 2021 |
| Evi Labs | 4 | powder | Over the counter monograph drugs | January 28, 2026 |
| Tender Corporation D/B/A Adventure Ready Brands | 4 | liquid; cream | Over the counter monograph drugs | June 17, 2025 |
| Twin Med LLC | 3 | tablet | Over the counter monograph drugs | March 1, 2026 |
| A-S Medication Solutions | 2 | injection, solution | Generic drugs (ANDA) | March 1, 2021 |
| Amneal Pharmaceuticals Private Limited | 2 | injection, solution | Generic drugs (ANDA) | July 13, 2026 |
| Citragen Pharmaceuticals Inc | 2 | tablet | Over the counter monograph drugs | April 20, 2018 |
| Cosmuses Cosmetics (Ningbo) Co., Ltd. | 2 | cloth; lotion | Over the counter monograph drugs | June 14, 2024 |
| DLC Laboratories, Inc. | 2 | powder; liquid | Over the counter monograph drugs | March 15, 2016 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | August 25, 2025 |
| Henry Schein, Inc. | 2 | injection, solution | Generic drugs (ANDA) | January 12, 2022 |
| Lotus Brands, Inc. | 2 | liquid | Over the counter monograph drugs | June 1, 2013 |
| Menper Distributors, Inc. | 2 | liquid; powder | Over the counter monograph drugs | January 1, 2017 |
| ProPharma Distribution | 2 | injection, solution; injection | Generic drugs (ANDA) | March 15, 2024 |
| Richmond Pharmaceuticals, Inc. | 2 | tablet | Over the counter monograph drugs | June 1, 2015 |
| Rugby Laboratories | 2 | tablet | Over the counter monograph drugs | March 25, 2015 |
| 78271 | 1 | gel | Over the counter monograph drugs | October 29, 2024 |
| Advanced Rx LLC | 1 | tablet | Over the counter monograph drugs | September 1, 2025 |
| Anthea Pharma Private Limited | 1 | injection, solution | Generic drugs (ANDA) | June 26, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Over the counter monograph drugs | March 25, 2015 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Over the counter monograph drugs | May 1, 2015 |
| Apnar Pharma LP | 1 | tablet | Over the counter monograph drugs | June 24, 2022 |
| Baxter Healthcare Corporation | 1 | injection, solution | New drug applications (NDA) | August 14, 2026 |
| Bryant Ranch Prepack | 1 | tablet | Over the counter monograph drugs | July 20, 2020 |
| Bryant Ranch Prepack | 1 | injection, solution | Generic drugs (ANDA) | June 16, 2023 |
| Cardinal Health 107, LLC | 1 | tablet | Over the counter monograph drugs | October 26, 2022 |
| Church & Dwight Co., Inc. | 1 | powder | Over the counter monograph drugs | January 1, 2000 |
| Civica, Inc. | 1 | injection, solution | Generic drugs (ANDA) | August 1, 2019 |
| Gendose Pharmaceuticals, LLC | 1 | tablet | Over the counter monograph drugs | May 1, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 1 | injection, solution | Generic drugs (ANDA) | August 7, 2025 |
| Graxcell Pharmaceutical, LLC | 1 | tablet | Over the counter monograph drugs | October 2, 2017 |
| Humco Holding Group, Inc | 1 | powder | Over the counter monograph drugs | November 9, 2017 |
| Humco Holding Group, Inc. | 1 | powder | Over the counter monograph drugs | March 25, 1998 |
| International Medication Systems, Limited | 1 | injection | Generic drugs (ANDA) | June 1, 2000 |
| Major Pharmaceuticals | 1 | tablet | Over the counter monograph drugs | October 26, 2022 |
| Milla Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | August 7, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Over the counter monograph drugs | March 25, 2015 |
| Omnivium Pharmaceuticals LLC. | 1 | injection, solution | Generic drugs (ANDA) | June 16, 2023 |
| Pharma Nobis, LLC | 1 | powder | Over the counter monograph drugs | October 27, 2017 |
| Pharmadel LLC | 1 | powder | Over the counter monograph drugs | November 23, 2020 |
| Reliable 1 Laboratories LLC | 1 | tablet, soluble | Over the counter monograph drugs | November 1, 2015 |
| Remedyrepack Inc. | 1 | injection | Generic drugs (ANDA) | August 14, 2024 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Over the counter monograph drugs | July 20, 2020 |
| Steriscience Specialties Private Limited | 1 | injection, solution | Generic drugs (ANDA) | March 8, 2024 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, solution | Generic drugs (ANDA) | March 15, 2024 |
| Vitamex USA, Corp | 1 | powder | Over the counter monograph drugs | May 1, 2026 |
| Westminster Pharmaceuticals, LLC | 1 | tablet | Over the counter monograph drugs | October 10, 2022 |
| World Perfumes Inc | 1 | powder | Over the counter monograph drugs | February 5, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 38 | 42.7% |
| Tablet | 21 | 23.6% |
| Powder | 13 | 14.6% |
| Liquid | 6 | 6.7% |
| Injection | 5 | 5.6% |
| Cream | 2 | 2.2% |
| Gel | 1 | 1.1% |
| Tablet, soluble | 1 | 1.1% |
| Cloth | 1 | 1.1% |
| Lotion | 1 | 1.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 46 | 51.7% |
| Generic drugs (ANDA) | 37 | 41.6% |
| Other unapproved drugs | 4 | 4.5% |
| New drug applications (NDA) | 2 | 2.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Osmotic Laxative | 41 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.